Shenzhen Kangtai Biological Products Co., Ltd. (SHE:300601)
China
· Delayed Price · Currency is CNY 14.17
+0.01 (0.07%)
Apr 29, 2026, 3:04 PM CST
SHE:300601 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 | 2021 - 2017 |
| Net Income | 81.24 | 70.33 | 201.65 | 861.3 | -132.71 | 1,263 | Upgrade
|
| Depreciation & Amortization | 393.73 | 393.73 | 317.24 | 201.39 | 200.95 | 404.71 | Upgrade
|
| Other Amortization | 39.65 | 39.65 | 36.22 | 39.33 | 28.1 | 28.35 | Upgrade
|
| Loss (Gain) From Sale of Assets | 0.93 | 0.93 | 8.42 | 1.35 | -0.13 | -0.03 | Upgrade
|
| Asset Writedown & Restructuring Costs | 14.9 | 14.9 | 15.57 | 3.32 | 624.09 | 3.41 | Upgrade
|
| Loss (Gain) From Sale of Investments | -6.8 | -6.8 | -1.85 | -1.89 | -4.12 | -29.71 | Upgrade
|
| Provision & Write-off of Bad Debts | 42.11 | 42.11 | 29.74 | 12.49 | 39.64 | 10.45 | Upgrade
|
| Other Operating Activities | 109.63 | 173.51 | 250.25 | 137.25 | 384.44 | 217.36 | Upgrade
|
| Change in Accounts Receivable | 159.19 | 159.19 | -20.26 | -417.18 | -488.76 | 273.88 | Upgrade
|
| Change in Inventory | 49.18 | 49.18 | -79.03 | 8.68 | 220.75 | -746.67 | Upgrade
|
| Change in Accounts Payable | -276.35 | -276.35 | -183.76 | 111.31 | -130.98 | 146.54 | Upgrade
|
| Change in Other Net Operating Assets | - | - | 86.99 | -3.19 | 9.97 | 29.95 | Upgrade
|
| Operating Cash Flow | 582.6 | 635.57 | 603.25 | 1,033 | 545.7 | 1,652 | Upgrade
|
| Operating Cash Flow Growth | -7.98% | 5.36% | -41.61% | 89.32% | -66.97% | 275.65% | Upgrade
|
| Capital Expenditures | -337 | -331.92 | -472.18 | -718.45 | -1,310 | -2,540 | Upgrade
|
| Sale of Property, Plant & Equipment | 0.65 | 0.3 | 16.15 | 0.96 | 0.08 | 0.19 | Upgrade
|
| Investment in Securities | -264 | -348 | -157.4 | 218 | -1,338 | 1,037 | Upgrade
|
| Other Investing Activities | 217.86 | 195.61 | 56.74 | 60.62 | 42.01 | 63.2 | Upgrade
|
| Investing Cash Flow | -382.48 | -484.01 | -556.69 | -438.87 | -2,606 | -1,440 | Upgrade
|
| Long-Term Debt Issued | - | 39.9 | 212.62 | 379.91 | 529.46 | 3,141 | Upgrade
|
| Long-Term Debt Repaid | - | -262.99 | -743.15 | -299.43 | -1,070 | -26.48 | Upgrade
|
| Net Debt Issued (Repaid) | -114.6 | -223.09 | -530.53 | 80.48 | -540.98 | 3,115 | Upgrade
|
| Issuance of Common Stock | - | - | - | - | 587.29 | 164.74 | Upgrade
|
| Repurchase of Common Stock | - | - | - | -100.99 | -20.55 | - | Upgrade
|
| Common Dividends Paid | -130.87 | -131.55 | -256.62 | -237.23 | -622.15 | -220.42 | Upgrade
|
| Other Financing Activities | 10.48 | 9.84 | -13.61 | -160.31 | 131.52 | -607.18 | Upgrade
|
| Financing Cash Flow | -234.99 | -344.81 | -800.76 | -418.05 | -464.88 | 2,452 | Upgrade
|
| Foreign Exchange Rate Adjustments | -2.22 | -0.96 | -0.06 | 0.04 | -1.66 | -0.98 | Upgrade
|
| Net Cash Flow | -37.1 | -194.21 | -754.26 | 176.22 | -2,527 | 2,663 | Upgrade
|
| Free Cash Flow | 245.6 | 303.65 | 131.07 | 314.65 | -764.7 | -888.15 | Upgrade
|
| Free Cash Flow Growth | 9.48% | 131.67% | -58.34% | - | - | - | Upgrade
|
| Free Cash Flow Margin | 9.24% | 11.36% | 4.94% | 9.05% | -24.22% | -24.32% | Upgrade
|
| Free Cash Flow Per Share | 0.21 | 0.26 | 0.12 | 0.28 | -0.69 | -0.80 | Upgrade
|
| Cash Income Tax Paid | 137.77 | 125.53 | 122.5 | 85.74 | 185.63 | 38.68 | Upgrade
|
| Levered Free Cash Flow | 1,884 | 198.6 | -275.34 | 78.23 | -887.61 | -1,972 | Upgrade
|
| Unlevered Free Cash Flow | 1,958 | 273 | -197.76 | 149.3 | -819.5 | -1,938 | Upgrade
|
| Change in Working Capital | -92.8 | -92.8 | -253.99 | -221.42 | -594.56 | -245.63 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.